Last reviewed · How we verify
NCT04599751
The Trio Laser Module for Hair Removal Treatment
NA trial testing Hair removal treatment in Hair Removal Treatment in 37 participants. Completed in 16 November 2021.
7 October 2021
Quick facts
| Lead sponsor | Alma Lasers |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 37 |
| Start date | 7 October 2020 |
| Primary completion | 7 October 2021 |
| Estimated completion | 16 November 2021 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Hair removal treatment
Conditions studied
- Hair Removal Treatment — all drugs for Hair Removal Treatment →
Sponsor
Alma Lasers
Who can join
Adults 18 to 70, any sex, with Hair Removal Treatment. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study is aimed to assess the safety and efficacy of hair removal treatments, using the Trio Laser Module (Alma Lasers). The study will include 36 subjects that will undergo axilla and bikini line hair removal treatments. Safety and efficacy will be evaluated 3- months after the last treatment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04599751
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Alma Lasers trials
Trials by the same sponsor.
- NCT06102343 — Safety and Efficacy Investigation on the Effects of ClearSkin Non-ablative ER:Glass 1540nm Laser Module in the Treatment · NA · unknown
- NCT05016674 — Assessment of Cellular and Tissue Characteristics in Lipoaspirates Stirred by VorFat · NA · withdrawn
- NCT04640207 — The Efficacy of the Alma Hybrid System for a New Approach of Facial Skin Treatment · NA · completed
- NCT04153071 — Unipolar Microplasma Radiofrequency Device: In-vivo Histologic Study · NA · withdrawn
- NCT03800563 — Laser Assisted Liposuction and Facial Autologous Fat Grafting With the LipoLife System · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04599751 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Alma Lasers
- Last refreshed: 17 November 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04599751.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing